Κυριακή 4 Δεκεμβρίου 2016

Corrigendum to ‘Targeting FGFR2 with alofanib (RPT835) shows potent activity in tumour models’ [Eur J Cancer 61 (2016) 20–28]

alertIcon.gif

Publication date: Available online 3 December 2016
Source:European Journal of Cancer
Author(s): Ilya Tsimafeyeu, John Ludes-Meyers, Evgenia Stepanova, Frits Daeyaert, Dmitry Khochenkov, Jean-Baptiste Joose, Eliso Solomko, Koen Van Akene, Nina Peretolchina, Wei Yin, Oxana Ryabaya, Mikhail Byakhov, Sergei Tjulandin




from Cancer via ola Kala on Inoreader http://ift.tt/2g7fjGn
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου